Toshiaki Shimakawa oversees investment activities at Headline and serves as CEO of IVS. He previously conducted biological research at RIKEN and founded 17LIVE’s Japanese subsidiary.

Unclaimed profile

Toshiaki Shimakawa oversees investment activities at Headline and serves as CEO of IVS. He previously conducted biological research at RIKEN and founded 17LIVE’s Japanese subsidiary.

Career

CEO at IVS from 2020 to Present
Principal at Headline until Present

Toshiaki's Collections

Toshiaki's Lists

In these lists

Cosigns Given